

NCT02974686 comparison:

Summary:
CHIA has 14 criteria while your personal folder has 14 criteria
Total found criteria: 12/14
Total not Found: 2/14
Total Extra: 4
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Kidney transplant recipients at Washington         │ Kidney transplant recipients at Washington         │
│ University/Barnes-Jewish Hospital                  │ University/Barnes-Jewish Hospital                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Experiencing GI toxicity from MPA as determined by │ Experiencing GI toxicity from MPA as determined by │
│ the treating physician within 12 months post-renal │ the treating physician within 12 months post-renal │
│ transplant                                         │ transplant                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ On standard immunosuppression with tacrolimus and  │ On standard immunosuppression with tacrolimus and  │
│ prednisone                                         │ prednisone                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Dual organ or kidney after another solid organ     │ Dual organ or kidney after another solid organ     │
│ transplant                                         │ transplant                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presence of a preexisting significant GI condition │ Presence of a preexisting significant GI condition │
│ that does not have a presumed causal relationship  │ that does not have a presumed causal relationship  │
│ with MPA                                           │ with MPA                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Evidence of any GI disorder induced by an          │ Evidence of any GI disorder induced by an          │
│ infection, underlying medical condition, or        │ infection, underlying medical condition, or        │
│ concomitant medication other than MPA              │ concomitant medication other than MPA              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Proteinuria >1 gram/day at time of possible        │ Proteinuria \>1 gram/day at time of possible       │
│ conversion                                         │ conversion                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hemoglobin <10 g/dL                                │ Hemoglobin \<10 g/dL                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Platelets <100 K/cumm                              │ Platelets \<100 K/cumm                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Wound healing issues at time of possible           │ Wound healing issues at time of possible           │
│ conversion (eg, wound dehiscence, wound infection, │ conversion (eg, wound dehiscence, wound infection, │
│ incisional hernia, lymphocele, seroma)             │ incisional hernia, lymphocele, seroma)             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Elevated total cholesterol (>350 mg/dL) and/or     │ Elevated total cholesterol (\>350 mg/dL) and/or    │
│ triglycerides (>500 ng/dL) at time of possible     │ triglycerides (\>500 ng/dL) at time of possible    │
│ conversion                                         │ conversion                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hypersensitivity to everolimus, sirolimus, or      │ Hypersensitivity to everolimus, sirolimus, or      │
│ other rapamycin deriviatives                       │ other rapamycin derivatives                        │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═══════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal           │
╞═══════════════════════════════════════════════╡
│ eGFR<40 ml/min at time of possible conversion │
├───────────────────────────────────────────────┤
│ WBC <3 K/cumm                                 │
╘═══════════════════════════════════════════════╛



╒════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                │
╞════════════════════════════════════════════════════════════════════════════════════════╡
│ Profound bone marrow suppression at the time of possible conversion as defined as      │
├────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                      │
├────────────────────────────────────────────────────────────────────────────────────────┤
│ White blood cell (WBC) \< 3 K/cumm                                                     │
├────────────────────────────────────────────────────────────────────────────────────────┤
│ Estimated glomerular filtration rate (eGFR) \<40 ml/min at time of possible conversion │
╘════════════════════════════════════════════════════════════════════════════════════════╛